About
GlySens is a pioneering company in the field of continuous glucose monitoring (CGM) technology. Their innovative implantable devices offer long-term, accurate glucose readings without the need for frequent calibration. This breakthrough technology aims to improve the quality of life for individuals with diabetes by providing more consistent and reliable glucose data.
The company’s flagship product, the GlySens Eclipse® ICGM System, is designed to be minimally invasive and user-friendly. It can be implanted under the skin, offering a hassle-free alternative to traditional CGM devices. This system has the potential to transform diabetes management by reducing the burden of daily glucose monitoring.
GlySens is committed to advancing diabetes care through cutting-edge research and development. Their work is supported by a team of experts in biomedical engineering, endocrinology, and sensor technology. With a focus on improving patient outcomes and simplifying diabetes management, GlySens continues to push the boundaries of what’s possible in glucose monitoring technology.
